Articles with "dexamethasone" as a keyword



High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2022.2168

Abstract: Importance The benefit of high-dose dexamethasone and oxygenation strategies vs standard of care for patients with severe acute hypoxemic respiratory failure (AHRF) caused by COVID-19 pneumonia is debated. Objectives To assess the benefit of high-dose… read more here.

Keywords: dose dexamethasone; trial; care; high dose ... See more keywords

Dexamethasone for Inpatients With COVID-19 in a National Cohort.

Sign Up to like & get
recommendations!
Published in 2023 at "JAMA network open"

DOI: 10.1001/jamanetworkopen.2023.8516

Abstract: Importance Limited effective therapeutics are available to hospitalized patients with COVID-19. Clinical trials and observational studies have shown varying effects of systemic corticosteroids, including dexamethasone, in hospitalized patients with COVID-19, with limited descriptions of important… read more here.

Keywords: supplemental oxygen; discharge hospice; mortality discharge; cohort ... See more keywords

Dexamethasone promotes mesenchymal stem cell apoptosis and inhibits osteogenesis by disrupting mitochondrial dynamics

Sign Up to like & get
recommendations!
Published in 2019 at "FEBS Open Bio"

DOI: 10.1002/2211-5463.12771

Abstract: Long‐term or heavy use of glucocorticoids can cause severe necrosis of the femoral head, but the underlying mechanisms are still unclear. Recent studies have found that mitochondrial dynamics play an important role in femoral head… read more here.

Keywords: apoptosis; mitochondrial dynamics; dexamethasone; cell ... See more keywords

Titanium‐Based Tannic Acid/Silver/Dexamethasone Composite Coatings with Antimicrobial and Osteoinductive Functions

Sign Up to like & get
recommendations!
Published in 2025 at "Advanced Engineering Materials"

DOI: 10.1002/adem.202500936

Abstract: The increasing demand for orthopedic biomaterials, driven by aging populations, has highlighted the limitations of titanium (Ti) and Ti‐alloys, including bacterial adhesion and implant failure. To address these issues, a novel dexamethasone/tannic acid/silver composite coating… read more here.

Keywords: acid silver; tannic acid; titanium; dexamethasone ... See more keywords

Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice

Sign Up to like & get
recommendations!
Published in 2023 at "American Journal of Hematology"

DOI: 10.1002/ajh.26866

Abstract: Patient‐reported outcomes in AL amyloidosis have not been well‐studied. We analyzed health‐related quality of life (HRQOL) and AL amyloidosis symptoms data from the phase 3 TOURMALINE‐AL1 trial (NCT01659658) (ixazomib‐dexamethasone, n = 85; physician's choice of… read more here.

Keywords: ixazomib dexamethasone; physician choice; patients relapsed; quality life ... See more keywords

Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis

Sign Up to like & get
recommendations!
Published in 2024 at "American Journal of Hematology"

DOI: 10.1002/ajh.27314

Abstract: In view of the increasing data evaluating carfilzomib-based induction for newly-diagnosed multiple myeloma (NDMM), we conducted a systematic review and meta-analysis comparing the efficacy of carfilzomib/lenalidomide/dexamethasone (KRd) versus bortezomib/lenalidomide/dexamethasone (VRd). Three studies totaling 1597 patients… read more here.

Keywords: krd; newly diagnosed; diagnosed multiple; dexamethasone ... See more keywords

Ixazomib combined with lenalidomide and dexamethasone chemotherapy for newly diagnosed multiple myeloma in China—Compared with bortezomib/lenalidomide/dexamethasone

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5198

Abstract: To compare the response and safety of Ixazomib/Lenalidomide/Dexamethasone (IRd) and Bortezomib/Lenalidomide/Dexamethasone (VRd) treatment in newly diagnosed multiple myeloma (MM). read more here.

Keywords: diagnosed multiple; newly diagnosed; lenalidomide dexamethasone; bortezomib lenalidomide ... See more keywords

Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5422

Abstract: The purpose of this prospective, randomized study was to investigate the effectiveness and safety of the ixazomib+cyclophosphamide+dexamethasone (ICd) and ixazomib+dexamethasone (Id) regimens in newly diagnosed multiple myeloma (NDMM) who were elderly and frail and to… read more here.

Keywords: cyclophosphamide dexamethasone; ixazomib cyclophosphamide; newly diagnosed; ixazomib dexamethasone ... See more keywords

Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Medicine"

DOI: 10.1002/cam4.5584

Abstract: Lenalidomide‐based regimens are commonly used for early relapse in patients with relapsed and/or refractory multiple myeloma (RRMM) receiving at least one prior line of therapy. In the absence of head‐to‐head comparison, matching‐adjusted indirect comparison (MAIC)… read more here.

Keywords: matching adjusted; indirect comparison; comparison; adjusted indirect ... See more keywords

The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID‐19 Patients: A Physiologically Based Pharmacokinetic Modeling Study

Sign Up to like & get
recommendations!
Published in 2024 at "Clinical Pharmacology and Therapeutics"

DOI: 10.1002/cpt.3491

Abstract: Dexamethasone (DEX) is currently the treatment of choice for patients with oxygen‐dependent COVID‐19. It has been observed, primarily in vitro, that dexamethasone induces the expression of CYP3A and the ABCB1 gene, which encodes P‐glycoprotein (P‐gp).… read more here.

Keywords: covid; dex; based pharmacokinetic; pharmacokinetic modeling ... See more keywords

Ultrasound‐guided adductor canal block after arthroscopic anterior cruciate ligament reconstruction: Effect of adding dexamethasone to bupivacaine, a randomized controlled trial

Sign Up to like & get
recommendations!
Published in 2019 at "European Journal of Pain"

DOI: 10.1002/ejp.1292

Abstract: Dexamethasone improves the quality and duration of peripheral nerve block when used as an adjuvant to local anaesthetic. We evaluated the effect of adding dexamethasone to bupivacaine on the duration of postoperative analgesia in patients… read more here.

Keywords: block; effect adding; adding dexamethasone; ultrasound guided ... See more keywords